{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:26:16Z","timestamp":1787016376937,"version":"build-2736575974"},"reference-count":190,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK125372"],"award-info":[{"award-number":["R01DK125372"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY028169"],"award-info":[{"award-number":["R01EY028169"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1124\/pharmrev.124.001074","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T12:05:20Z","timestamp":1727352320000},"page":"100003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prospects for the convergence of polyphenols with pharmaceutical drugs in type 2 diabetes: Challenges, risks, and strategies"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7958-262X","authenticated-orcid":false,"given":"S.","family":"Allamreddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0262-5170","authenticated-orcid":false,"given":"R.","family":"Ganugula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Friend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5606-401X","authenticated-orcid":false,"given":"M.N.V. Ravi","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/pharmrev.124.001074_bib1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/gels9060494","article-title":"Optimization of potential nanoemulgels for boosting transdermal glimepiride delivery and upgrading its anti-diabetic activity","volume":"9","author":"Abdallah","year":"2023","journal-title":"Gels"},{"key":"10.1124\/pharmrev.124.001074_bib2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2337\/dc20-0978","article-title":"Durability of triple combination therapy versus stepwise addition therapy in patients with new-onset T2DM: 3-year follow-up of EDICT","volume":"44","author":"Abdul-Ghani","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1124\/pharmrev.124.001074_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/dom.12417","volume":"17","author":"Abdul-Ghani","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/pharmrev.124.001074_bib4","doi-asserted-by":"crossref","first-page":"21i","DOI":"10.1016\/j.amjcard.2007.03.003","article-title":"Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods","volume":"99","author":"Buse","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1124\/pharmrev.124.001074_bib5","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s001250100612","article-title":"Study rationale and design of ADVANCE: action in diabetes and vascular disease\u2014preterax and Diamicron MR controlled evaluation","volume":"44","year":"2001","journal-title":"Diabetologia"},{"key":"10.1124\/pharmrev.124.001074_bib6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/cbf.3738","article-title":"Metformin encapsulated gold nanoparticles (MTF-GNPs): a promising antiglycation agent","volume":"40","author":"Alenazi","year":"2022","journal-title":"Cell Biochem Funct"},{"key":"10.1124\/pharmrev.124.001074_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301759","article-title":"Electroactive polymers for on-demand drug release","volume":"13","author":"Alkahtani","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"10.1124\/pharmrev.124.001074_bib8","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/antiox12020416","article-title":"Insights on dietary polyphenols as agents against metabolic disorders: obesity as a target disease","volume":"12","author":"Aloo","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1124\/pharmrev.124.001074_bib9","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2337\/diacare.26.8.2231","article-title":"Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients","volume":"26","author":"Alvarsson","year":"2003","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1124\/pharmrev.124.001074_bib10","first-page":"s28","article-title":"Implications of the United Kingdom Prospective Diabetes Study","volume":"25","year":"2002","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1124\/pharmrev.124.001074_bib11","first-page":"S125","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1124\/pharmrev.124.001074_bib12","first-page":"S158","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1124\/pharmrev.124.001074_bib13","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/1932296817691303","article-title":"Oral insulin delivery in a physiologic context: review","volume":"11","author":"Arbit","year":"2017","journal-title":"J\u00a0Diabetes Sci Technol"},{"key":"10.1124\/pharmrev.124.001074_bib14","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s10787-021-00879-8","article-title":"Free fatty acid receptor 1: a ray of hope in the therapy of type 2 diabetes mellitus","volume":"29","author":"Arora","year":"2021","journal-title":"Inflammopharmacology"},{"key":"10.1124\/pharmrev.124.001074_bib15","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/nu8120785","article-title":"Polyphenols and DNA damage: a mixed blessing","volume":"8","author":"Azqueta","year":"2016","journal-title":"Nutrients"},{"key":"10.1124\/pharmrev.124.001074_bib16","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3390\/ph14080806","article-title":"Pharmaceutical drugs and natural therapeutic products for the treatment of type 2 diabetes mellitus","volume":"14","author":"Blahova","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1124\/pharmrev.124.001074_bib17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/nure.12114","article-title":"Dietary factors affecting polyphenol bioavailability","volume":"72","author":"Bohn","year":"2014","journal-title":"Nutr Rev"},{"key":"10.1124\/pharmrev.124.001074_bib18","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1080\/01480545.2020.1802475","article-title":"The effect of co-administration of berberine, resveratrol, and glibenclamide on xenobiotic metabolizing enzyme activities in diabetic rat liver","volume":"45","author":"Bozcaarmutlu","year":"2022","journal-title":"Drug Chem Toxicol"},{"key":"10.1124\/pharmrev.124.001074_bib19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s40271-014-0068-x","article-title":"Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities","volume":"7","author":"Brod","year":"2014","journal-title":"Patient"},{"key":"10.1124\/pharmrev.124.001074_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11136-008-9419-1","article-title":"Psychological insulin resistance: patient beliefs and implications for diabetes management","volume":"18","author":"Brod","year":"2009","journal-title":"Qual Life Res"},{"key":"10.1124\/pharmrev.124.001074_bib21","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"10.1124\/pharmrev.124.001074_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/dia.2019.0185","article-title":"Oral semaglutide: a review of the first oral glucagon-like peptide 1 receptor agonist","volume":"22","author":"Bucheit","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"10.1124\/pharmrev.124.001074_bib23","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S2213-8587(15)00097-2","article-title":"New forms of insulin and insulin therapies for the treatment of type 2 diabetes","volume":"3","author":"Cahn","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1124\/pharmrev.124.001074_bib24","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1007\/s00125-022-05778-3","article-title":"Precision medicine in type 1 diabetes","volume":"65","author":"Carr","year":"2022","journal-title":"Diabetologia"},{"key":"10.1124\/pharmrev.124.001074_bib25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4155\/tde-2019-0019","article-title":"Formulation and characterization of glibenclamide and quercetin-loaded chitosan nanogels targeting skin permeation","volume":"10","author":"Chellappan","year":"2019","journal-title":"Ther Deliv"},{"key":"10.1124\/pharmrev.124.001074_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.diabres.2006.07.001","article-title":"The significance of tumor necrosis factor-alpha in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment","volume":"75","author":"Chen","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1124\/pharmrev.124.001074_bib27","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2337\/dc08-0075","article-title":"Beneficial effects of insulin on glycemic control and \u03b2-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy","volume":"31","author":"Chen","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1124\/pharmrev.124.001074_bib28","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1111\/bph.14980","article-title":"HWL-088, a new potent free fatty acid receptor 1 (FFAR1) agonist, improves glucolipid metabolism and acts additively with metformin in ob\/ob diabetic mice","volume":"177","author":"Chen","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.124.001074_bib29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s40005-020-00480-1","article-title":"Emerging nanoparticulate drug delivery systems of metformin","volume":"50","author":"Chen","year":"2020","journal-title":"J\u00a0Pharm Investig"},{"key":"10.1124\/pharmrev.124.001074_bib30","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1038\/s41598-020-62646-z","article-title":"Clinical outcomes of basal insulin and oral antidiabetic agents as an add-on to dual therapy in patients with type 2 diabetes mellitus","volume":"10","author":"Cheng","year":"2020","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.124.001074_bib31","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/CIRCRESAHA.110.223552","article-title":"Epigenetics: mechanisms and implications for diabetic complications","volume":"107","author":"Cooper","year":"2010","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.124.001074_bib32","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cell.2007.08.021","article-title":"Molecular understanding and modern application of traditional medicines: triumphs and trials","volume":"130","author":"Corson","year":"2007","journal-title":"Cell"},{"key":"10.1124\/pharmrev.124.001074_bib33","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1208\/s12248-009-9144-x","article-title":"Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs","volume":"11","author":"Dahan","year":"2009","journal-title":"AAPS J"},{"key":"10.1124\/pharmrev.124.001074_bib34","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1089\/dia.2016.0372","article-title":"Minimizing glycemic fluctuations in patients with type 2 diabetes: approaches and importance","volume":"19","author":"Dandona","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.1124\/pharmrev.124.001074_bib35","first-page":"511","article-title":"Anti-inflammatory effects of insulin","volume":"10","author":"Dandona","year":"2007","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1124\/pharmrev.124.001074_bib36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10517-021-05191-7","article-title":"Oxidative stress: pathogenetic role in diabetes mellitus and its complications and therapeutic approaches to correction","volume":"171","author":"Darenskaya","year":"2021","journal-title":"Bull Exp Biol Med"},{"key":"10.1124\/pharmrev.124.001074_bib37","doi-asserted-by":"crossref","first-page":"9713","DOI":"10.1038\/s41598-022-13647-7","article-title":"Curcumin and metformin synergistically modulate peripheral and central immune mechanisms of pain","volume":"12","author":"Dasuni Wasana","year":"2022","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.124.001074_bib38","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00125-022-05787-2","article-title":"Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"65","author":"Davies","year":"2022","journal-title":"Diabetologia"},{"key":"10.1124\/pharmrev.124.001074_bib39","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00125-018-4729-5","article-title":"Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"61","author":"Davies","year":"2018","journal-title":"Diabetologia"},{"key":"10.1124\/pharmrev.124.001074_bib40","first-page":"1","article-title":"Drug delivery systems for challenging molecules","volume":"176","author":"Davis","year":"1998","journal-title":"Int J Pharm"},{"key":"10.1124\/pharmrev.124.001074_bib41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2337\/diacare.13.4.427","article-title":"Diabetes Control and Complications Trial (DCCT). Update","volume":"13","year":"1990","journal-title":"Diabetes Care"},{"key":"10.1124\/pharmrev.124.001074_bib42","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3390\/nu15040996","article-title":"The (poly)phenol-carbohydrate combination for diabetes: where do we stand?","volume":"15","author":"de Matos","year":"2023","journal-title":"Nutrients"},{"key":"10.1124\/pharmrev.124.001074_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2021.110383","article-title":"Antidiabetic potential of dietary polyphenols: a mechanistic review","volume":"145","author":"de Paulo Farias","year":"2021","journal-title":"Food Res Int"},{"key":"10.1124\/pharmrev.124.001074_bib44","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/BF00400466","article-title":"Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man","volume":"37","author":"Del Prato","year":"1994","journal-title":"Diabetologia"},{"key":"10.1124\/pharmrev.124.001074_bib45","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1002\/ptr.7564","article-title":"The role of selected nutraceuticals in management of prediabetes and diabetes: an updated review of the literature","volume":"36","author":"Derosa","year":"2022","journal-title":"Phytother Res"},{"key":"10.1124\/pharmrev.124.001074_bib46","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.3390\/ijms21062217","article-title":"Plant-based antidiabetic nanoformulations: the emerging paradigm for effective therapy","volume":"21","author":"Dewanjee","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.124.001074_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117856","article-title":"Beneficial effects of ferulic acid alone and in combination with insulin in streptozotocin induced diabetic neuropathy in Sprague Dawley rats","volume":"255","author":"Dhaliwal","year":"2020","journal-title":"Life Sci"},{"key":"10.1124\/pharmrev.124.001074_bib48","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3390\/molecules22060903","article-title":"The antidiabetic mechanisms of polyphenols related to increased glucagon-like peptide-1 (GLP1) and insulin signaling","volume":"22","author":"Dom\u00ednguez Avila","year":"2017","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.124.001074_bib49","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.1461","article-title":"Triple therapy in type 2 diabetes; a systematic review and network meta-analysis","volume":"3","author":"Downes","year":"2015","journal-title":"PeerJ"},{"key":"10.1124\/pharmrev.124.001074_bib50","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.3390\/molecules28062536","article-title":"Possible side effects of polyphenols and their interactions with medicines","volume":"28","author":"Duda-Chodak","year":"2023","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.124.001074_bib51","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1021\/acs.molpharmaceut.2c00465","article-title":"Oral nanocurcumin alone or in combination with insulin alleviates STZ-induced diabetic neuropathy in rats","volume":"19","author":"Dwivedi","year":"2022","journal-title":"Mol Pharm"},{"key":"10.1124\/pharmrev.124.001074_bib52","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.91863","article-title":"Insulin\u2019s direct hepatic effect explains the inhibition of glucose production caused by insulin secretion","volume":"2","author":"Edgerton","year":"2017","journal-title":"JCI Insight"},{"key":"10.1124\/pharmrev.124.001074_bib53","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.2337\/db14-0266","article-title":"Changes in glucose and fat metabolism in response to the administration of a hepato-preferential insulin analog","volume":"63","author":"Edgerton","year":"2014","journal-title":"Diabetes"},{"key":"10.1124\/pharmrev.124.001074_bib54","article-title":"Design, optimization, and in-vivo performance of glipizide-loaded O-carboxymethyl chitosan nanoparticles in insulin resistant\/type 2 diabetic rat model","volume":"79","author":"El-Dakroury","year":"2023","journal-title":"J\u00a0Drug Deliv Sci Technol"},{"key":"10.1124\/pharmrev.124.001074_bib55","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/dom.14901","article-title":"Oral insulin (ORMD-0801) in type 2 diabetes mellitus: a dose-finding 12-week randomized placebo-controlled study","volume":"25","author":"Eldor","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/pharmrev.124.001074_bib56","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s00125-020-05245-x","article-title":"Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia","volume":"63","author":"Esser","year":"2020","journal-title":"Diabetologia"},{"key":"10.1124\/pharmrev.124.001074_bib57","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/21691401.2017.1347879","article-title":"Nano-encapsulated metformin-curcumin in PLGA\/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells","volume":"46","author":"Farajzadeh","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"10.1124\/pharmrev.124.001074_bib58","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1007\/s00125-021-05539-8","article-title":"The legacy effect in diabetes: are there long-term benefits?","volume":"64","author":"Folz","year":"2021","journal-title":"Diabetologia"},{"key":"10.1124\/pharmrev.124.001074_bib59","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/193229681300700228","article-title":"Oral insulin delivery: how far are we?","volume":"7","author":"Fonte","year":"2013","journal-title":"J\u00a0Diabetes Sci Technol"},{"key":"10.1124\/pharmrev.124.001074_bib60","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2181747","article-title":"Formulation of novel niosomal repaglinide chewable tablets using coprocessed excipients: in\u00a0vitro characterization, optimization and enhanced hypoglycemic activity in rats","volume":"30","author":"Fouad","year":"2023","journal-title":"Drug Deliv"},{"issue":"Suppl 2","key":"10.1124\/pharmrev.124.001074_bib61","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.2337\/dc11-s220","article-title":"Hypoglycemia and cardiovascular risks","volume":"34","author":"Frier","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1124\/pharmrev.124.001074_bib62","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/10717544.2021.2018524","article-title":"Synthesized nano particles of glimepiride via spray freezing into cryogenic liquid: characterization, antidiabetic activity, and bioavailability","volume":"29","author":"Gaber","year":"2022","journal-title":"Drug Deliv"},{"key":"10.1124\/pharmrev.124.001074_bib63","doi-asserted-by":"crossref","first-page":"6857","DOI":"10.1021\/acsnano.3c00535","article-title":"Systemic anti-inflammatory therapy aided by curcumin-laden double-headed nanoparticles combined with injectable long-acting insulin in a rodent model of diabetes eye disease","volume":"17","author":"Ganugula","year":"2023","journal-title":"ACS Nano"},{"key":"10.1124\/pharmrev.124.001074_bib64","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1021\/acsmacrolett.7b00035","article-title":"Noncompetitive active transport exploiting intestinal transferrin receptors for oral delivery of proteins by tunable nanoplatform","volume":"6","author":"Ganugula","year":"2017","journal-title":"ACS Macro Lett"},{"key":"10.1124\/pharmrev.124.001074_bib65","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jconrel.2022.12.012","article-title":"Nanocurcumin combined with insulin alleviates diabetic kidney disease through P38\/P53 signaling axis","volume":"353","author":"Ganugula","year":"2023","journal-title":"J\u00a0Control Release"},{"key":"10.1124\/pharmrev.124.001074_bib66","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jphp.12852","article-title":"Oral insulin delivery: existing barriers and current counter-strategies","volume":"70","author":"Gedawy","year":"2018","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1124\/pharmrev.124.001074_bib67","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.124.001074_bib68","first-page":"735","article-title":"Afrezza (insulin human) inhalation powder: a new inhaled insulin for the management of type-1 or type-2 diabetes mellitus","volume":"40","author":"Goldberg","year":"2015","journal-title":"P\u00a0T"},{"key":"10.1124\/pharmrev.124.001074_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012399","article-title":"Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARalpha, PPARgamma and LXRalpha","volume":"5","author":"Goldwasser","year":"2010","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.124.001074_bib70","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/09205063.2023.2279792","article-title":"Exploring the potential of pH-sensitive polymers in targeted drug delivery","volume":"35","author":"Gomte","year":"2024","journal-title":"J\u00a0Biomater Sci Polym Ed"},{"key":"10.1124\/pharmrev.124.001074_bib71","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f4533","article-title":"Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis","volume":"347","author":"Goto","year":"2013","journal-title":"BMJ"},{"key":"10.1124\/pharmrev.124.001074_bib72","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.3390\/nu15153454","article-title":"Polyphenols and their impact on the prevention of neurodegenerative diseases and development","volume":"15","author":"Grabska-Koby\u0142ecka","year":"2023","journal-title":"Nutrients"},{"key":"10.1124\/pharmrev.124.001074_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078217","article-title":"Efficacy of biodegradable curcumin nanoparticles in delaying cataract in diabetic rat model","volume":"8","author":"Grama","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.124.001074_bib74","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1021\/acsabm.2c01001","article-title":"Encapsulation of pioglitazone into polymer-nanoparticles for potential treatment of atherosclerotic diseases","volume":"6","author":"Groner","year":"2023","journal-title":"ACS Appl Bio Mater"},{"key":"10.1124\/pharmrev.124.001074_bib75","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/1567201818666210614100603","article-title":"Assessment of exenatide loaded biotinylated trimethylated chitosan\/HP-55 nanoparticles","volume":"19","author":"Guo","year":"2022","journal-title":"Curr Drug Deliv"},{"key":"10.1124\/pharmrev.124.001074_bib76","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S2213-8587(18)30372-3","article-title":"Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial","volume":"7","author":"Halberg","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1124\/pharmrev.124.001074_bib77","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s13300-020-00855-5","article-title":"Rationale for timely insulin therapy in type 2 diabetes within the framework of individualised treatment: 2020 update","volume":"11","author":"Hanefeld","year":"2020","journal-title":"Diabetes Ther"},{"key":"10.1124\/pharmrev.124.001074_bib78","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1208\/s12248-023-00839-w","article-title":"Glucose-responsive microgel comprising conventional insulin and curcumin-laden nanoparticles: a potential combination for diabetes management","volume":"25","author":"Heyns","year":"2023","journal-title":"AAPS J"},{"key":"10.1124\/pharmrev.124.001074_bib79","doi-asserted-by":"crossref","first-page":"45651","DOI":"10.1021\/acsami.3c09866","article-title":"Rationally designed naringenin-conjugated polyester nanoparticles enable folate receptor-mediated peroral delivery of insulin","volume":"15","author":"Heyns","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1124\/pharmrev.124.001074_bib80","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-Year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1124\/pharmrev.124.001074_bib81","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.3390\/molecules28062471","article-title":"A\u00a0novel drug delivery system: hyodeoxycholic acid-modified metformin liposomes for type 2 diabetes treatment","volume":"28","author":"Hu","year":"2023","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.124.001074_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109767","article-title":"A\u00a0review on the potential of resveratrol in prevention and therapy of diabetes and diabetic complications","volume":"125","author":"Huang","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1124\/pharmrev.124.001074_bib83","series-title":"Diabetes Atlas 2021","year":"2022"},{"key":"10.1124\/pharmrev.124.001074_bib84","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11095-019-2620-9","article-title":"Synthesis and statistical optimization of poly (lactic-co-glycolic acid) nanoparticles encapsulating GLP1 analog designed for oral delivery","volume":"36","author":"Ismail","year":"2019","journal-title":"Pharm Res"},{"key":"10.1124\/pharmrev.124.001074_bib85","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2174\/1567201817666201026105611","article-title":"Repaglinide and metformin-loaded Amberlite resin-based floating microspheres for the effective management of type 2 diabetes","volume":"18","author":"Jain","year":"2021","journal-title":"Curr Drug Deliv"},{"key":"10.1124\/pharmrev.124.001074_bib86","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41580-021-00390-6","article-title":"The aetiology and molecular landscape of insulin resistance","volume":"22","author":"James","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1124\/pharmrev.124.001074_bib87","first-page":"7","article-title":"Material design for oral insulin delivery","volume":"1","author":"Ji","year":"2023","journal-title":"Med X"},{"key":"10.1124\/pharmrev.124.001074_bib88","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1007\/s00125-021-05505-4","article-title":"On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes","volume":"64","author":"Johnson","year":"2021","journal-title":"Diabetologia"},{"key":"10.1124\/pharmrev.124.001074_bib89","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","article-title":"Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future","volume":"383","author":"Kahn","year":"2014","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.124.001074_bib90","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"key":"10.1124\/pharmrev.124.001074_bib91","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40265-023-01847-y","article-title":"Teplizumab: first approval","volume":"83","author":"Keam","year":"2023","journal-title":"Drugs"},{"key":"10.1124\/pharmrev.124.001074_bib92","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/dom.12446","article-title":"Short-term administration of the glucagon receptor antagonist LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes","volume":"17","author":"Kelly","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/pharmrev.124.001074_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172625","article-title":"Treatment strategies against diabetes: success so far and challenges ahead","volume":"862","author":"Khursheed","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.124.001074_bib94","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/nu8010017","article-title":"Polyphenols and glycemic control","volume":"8","author":"Kim","year":"2016","journal-title":"Nutrients"},{"key":"10.1124\/pharmrev.124.001074_bib95","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/dom.14059","article-title":"Comparison of tofogliflozin versus glimepiride as the third oral agent added to metformin plus a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes: a randomized, 24-week, open-label, controlled trial (STOP-OB)","volume":"22","author":"Kitazawa","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/pharmrev.124.001074_bib96","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1124\/jpet.123.001679","article-title":"Pramlintide an adjunct to insulin therapy: challenges and recent progress in delivery","volume":"388","author":"Kommera","year":"2024","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.124.001074_bib97","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/cpt.1215","article-title":"Clinical evaluation of MK-2640: an insulin analog with glucose-responsive properties","volume":"105","author":"Krug","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pharmrev.124.001074_bib98","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.tips.2021.05.005","article-title":"Commemorating insulin's centennial: engineering insulin pharmacology towards physiology","volume":"42","author":"Kurtzhals","year":"2021","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pharmrev.124.001074_bib99","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jdiacomp.2016.07.023","article-title":"Ten-year hemoglobin A1c trajectories and outcomes in type 2 diabetes mellitus: the Diabetes & Aging Study","volume":"31","author":"Laiteerapong","year":"2017","journal-title":"J\u00a0Diabetes Complications"},{"key":"10.1124\/pharmrev.124.001074_bib100","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/nu13020334","article-title":"Berries as a treatment for obesity-induced inflammation: evidence from preclinical models","volume":"13","author":"Land Lail","year":"2021","journal-title":"Nutrients"},{"key":"10.1124\/pharmrev.124.001074_bib101","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1080\/14656566.2022.2141569","article-title":"Efficacy and safety of tregopil, a novel, ultra-rapid acting oral prandial insulin analog, as part of a basal-bolus regimen in type 2 diabetes: a randomized, active-controlled phase 2\/3 study","volume":"23","author":"Lebovitz","year":"2022","journal-title":"Expert Opin Pharmacother"},{"key":"10.1124\/pharmrev.124.001074_bib102","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/ajhp\/zxac244","article-title":"Anti-CD3 monoclonal antibodies for the prevention and treatment of type 1 diabetes: a literature review","volume":"79","author":"LeFevre","year":"2022","journal-title":"Am J Health Syst Pharm"},{"key":"10.1124\/pharmrev.124.001074_bib103","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","article-title":"Trends in insulin resistance: insights into mechanisms and therapeutic strategy","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1124\/pharmrev.124.001074_bib104","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.2337\/diacare.27.11.2597","article-title":"Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function","volume":"27","author":"Li","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1124\/pharmrev.124.001074_bib105","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2337\/dc09-0653","article-title":"Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: which is better?","volume":"32","author":"Lingvay","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1124\/pharmrev.124.001074_bib106","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.addr.2016.04.029","article-title":"Rule of five in 2015 and beyond: target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions","volume":"101","author":"Lipinski","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/pharmrev.124.001074_bib107","article-title":"Glucose-responsive charge-switchable lipid nanoparticles for insulin delivery","volume":"62","author":"Liu","year":"2023","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1124\/pharmrev.124.001074_bib108","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1208\/s12249-022-02402-w","article-title":"Metformin hydrochloride mucosal nanoparticles-based enteric capsule for prolonged intestinal residence time, improved bioavailability, and hypoglycemic effect","volume":"24","author":"Lu","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1124\/pharmrev.124.001074_bib109","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ajcn\/79.5.727","article-title":"Polyphenols: food sources and bioavailability","volume":"79","author":"Manach","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"Suppl 4","key":"10.1124\/pharmrev.124.001074_bib110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1463-1326.2008.00939.x","article-title":"Relationship between \u03b2-cell mass and diabetes onset","volume":"10","author":"Matveyenko","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/pharmrev.124.001074_bib111","article-title":"Towards a stem-cell therapy for diabetes","author":"Melidoni","year":"2021","journal-title":"Nature Milestones: Diabetes"},{"key":"10.1124\/pharmrev.124.001074_bib112","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.3390\/nu14173563","article-title":"Updated information of the effects of (poly)phenols against type-2 diabetes mellitus in humans: reinforcing the recommendations for future research","volume":"14","author":"Menezes","year":"2022","journal-title":"Nutrients"},{"key":"10.1124\/pharmrev.124.001074_bib113","doi-asserted-by":"crossref","DOI":"10.1093\/rb\/rbac056","article-title":"Recent advances in glucose-responsive insulin delivery systems: novel hydrogels and future applications","volume":"9","author":"Mohanty","year":"2022","journal-title":"Regen Biomater"},{"key":"10.1124\/pharmrev.124.001074_bib114","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/10408363.2019.1648376","article-title":"Polyphenols targeting diabetes via the AMP-activated protein kinase pathway; future approach to drug discovery","volume":"56","author":"Momtaz","year":"2019","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1124\/pharmrev.124.001074_bib115","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1521-690X(03)00036-8","article-title":"Regulation of hepatic and peripheral glucose disposal","volume":"17","author":"Moore","year":"2003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1124\/pharmrev.124.001074_bib116","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13300-016-0214-7","article-title":"How can a good idea fail? Basal insulin peglispro [LY2605541] for the treatment of type 2 diabetes","volume":"8","author":"Mu\u00f1oz-Garach","year":"2017","journal-title":"Diabetes Ther"},{"key":"10.1124\/pharmrev.124.001074_bib117","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1001\/jama.2015.9536","article-title":"Diabetes: advances in diagnosis and treatment","volume":"314","author":"Nathan","year":"2015","journal-title":"JAMA"},{"key":"10.1124\/pharmrev.124.001074_bib118","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2147\/IJN.S235290","article-title":"Lipid-based gliclazide nanoparticles for treatment of diabetes: formulation, pharmacokinetics, pharmacodynamics and subacute toxicity study","volume":"15","author":"Nazief","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"10.1124\/pharmrev.124.001074_bib119","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1021\/acsnano.2c05824","article-title":"Highly retina-permeating and long-acting resveratrol\/metformin nanotherapeutics for enhanced treatment of macular degeneration","volume":"17","author":"Nguyen","year":"2023","journal-title":"ACS Nano"},{"key":"10.1124\/pharmrev.124.001074_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.877797","article-title":"New hypoglycemic drugs: combination drugs and targets discovery","volume":"13","author":"Ni","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.124.001074_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.798329","article-title":"Mechanisms underlying the antidiabetic activities of polyphenolic compounds: a review","volume":"12","author":"Nie","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.124.001074_bib122","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1021\/jf0483873","article-title":"Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice","volume":"53","author":"Nishiyama","year":"2005","journal-title":"J\u00a0Agric Food Chem"},{"key":"10.1124\/pharmrev.124.001074_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2023.171003","article-title":"The molecular pharmacology of glucagon agonists in diabetes and obesity","volume":"165","author":"Novikoff","year":"2023","journal-title":"Peptides"},{"key":"10.1124\/pharmrev.124.001074_bib124","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2337\/diaspect.29.3.180","article-title":"Commentary: why was inhaled insulin a failure in the market?","volume":"29","author":"Oleck","year":"2016","journal-title":"Diabetes Spectr"},{"key":"10.1124\/pharmrev.124.001074_bib125","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.2337\/dc12-2238","article-title":"Characteristics associated with maintenance of mean A1C<6.5% in people with dysglycemia in the ORIGIN trial","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1124\/pharmrev.124.001074_bib126","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.3390\/ijms22062852","article-title":"Potential enhancement of metformin hydrochloride in lipid vesicles targeting therapeutic efficacy in diabetic treatment","volume":"22","author":"Ossai","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.124.001074_bib127","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1089\/dia.2013.0081","article-title":"Clinical evidence for the earlier initiation of insulin therapy in type 2 diabetes","volume":"15","author":"Owens","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"10.1124\/pharmrev.124.001074_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110708","article-title":"Type II diabetes mellitus: a review on recent drug based therapeutics","volume":"131","author":"Padhi","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1124\/pharmrev.124.001074_bib129","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2337\/diab.41.10.1247","article-title":"Insulin is required for the liver to respond to intraportal glucose delivery in the conscious dog","volume":"41","author":"Pagliassotti","year":"1992","journal-title":"Diabetes"},{"key":"10.1124\/pharmrev.124.001074_bib130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/07853890.2015.1137630","article-title":"Metabolomics in diabetes, a review","volume":"48","author":"Pallares-M\u00e9ndez","year":"2016","journal-title":"Ann Med"},{"key":"10.1124\/pharmrev.124.001074_bib131","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53996-4","article-title":"Fabrication of second generation smarter PLGA based nanocrystal carriers for improvement of drug delivery and therapeutic efficacy of gliclazide in type-2 diabetes rat model","volume":"9","author":"Panda","year":"2019","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.124.001074_bib132","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1208\/s12249-018-1214-x","article-title":"Quality by design approach for developing lipid-based nanoformulations of gliclazide to improve oral bioavailability and anti-diabetic activity","volume":"20","author":"Patel","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1124\/pharmrev.124.001074_bib133","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.mce.2017.07.024","article-title":"Beneficial metabolic effects of dietary epigallocatechin gallate alone and in combination with exendin-4 in high fat diabetic mice","volume":"460","author":"Pathak","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/pharmrev.124.001074_bib134","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1080\/13880209.2021.2002369","article-title":"In\u00a0vitro-in\u00a0vivo availability of metformin hydrochloride-PLGA nanoparticles in diabetic rats in a periodontal disease experimental model","volume":"59","author":"Pereira","year":"2021","journal-title":"Pharm Biol"},{"key":"10.1124\/pharmrev.124.001074_bib135","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/er.2007-0023","article-title":"Glucolipotoxicity: fuel excess and \u03b2-cell dysfunction","volume":"29","author":"Poitout","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1124\/pharmrev.124.001074_bib136","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.diabet.2016.11.007","article-title":"Basal insulin treatment intensification in patients with type 2 diabetes mellitus: a comprehensive systematic review of current options","volume":"43","author":"Raccah","year":"2017","journal-title":"Diabetes Metab"},{"key":"10.1124\/pharmrev.124.001074_bib137","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.36740\/WLek202109212","article-title":"Linagliptin and gliclazide di-loaded extended-release nanoparticles: formulation and evaluation","volume":"74","author":"Rahi","year":"2021","journal-title":"Wiad Lek"},{"key":"10.1124\/pharmrev.124.001074_bib138","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5530\/pc.2012.3.4","article-title":"Pharmacokinetic and pharmacodynamic interaction of curcumin with glimepiride in normal and diabetic rats","volume":"2","author":"Rani","year":"2012","journal-title":"Pharmacog Commun"},{"key":"10.1124\/pharmrev.124.001074_bib139","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jconrel.2006.04.015","article-title":"Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective","volume":"113","author":"Ratnam","year":"2006","journal-title":"J\u00a0Control Release"},{"issue":"Suppl 2","key":"10.1124\/pharmrev.124.001074_bib140","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.2337\/dcS13-2014","article-title":"Early insulinization to prevent diabetes progression","volume":"36","author":"Raz","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1124\/pharmrev.124.001074_bib141","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00125-014-3462-y","article-title":"Epigenetic mechanisms in diabetic complications and metabolic memory","volume":"58","author":"Reddy","year":"2015","journal-title":"Diabetologia"},{"key":"10.1124\/pharmrev.124.001074_bib142","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(08)60736-9","article-title":"Intensive insulin therapy in newly diagnosed type 2 diabetes","volume":"371","author":"Retnakaran","year":"2008","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.124.001074_bib143","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1463-1326.2009.01129.x","article-title":"The response to short-term intensive insulin therapy in type 2 diabetes","volume":"12","author":"Retnakaran","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/pharmrev.124.001074_bib144","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2213-8587(14)70088-9","article-title":"Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial","volume":"2","author":"Ritsinger","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1124\/pharmrev.124.001074_bib145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1753944717711379","article-title":"Metabolic syndrome: pathophysiology, management, and modulation by natural compounds","volume":"11","author":"Rochlani","year":"2017","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1124\/pharmrev.124.001074_bib146","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/jama.2019.2942","article-title":"Effect of additional oral semaglutide vs sitagliptin on glycated hemoglobin in adults with type 2 diabetes uncontrolled with metformin alone or with sulfonylurea: the PIONEER 3 randomized clinical trial","volume":"321","author":"Rosenstock","year":"2019","journal-title":"JAMA"},{"key":"10.1124\/pharmrev.124.001074_bib147","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13098-019-0431-0","article-title":"Curcumin combined with metformin decreases glycemia and dyslipidemia, and increases paraoxonase activity in diabetic rats","volume":"11","author":"Roxo","year":"2019","journal-title":"Diabetol Metab Syndr"},{"key":"10.1124\/pharmrev.124.001074_bib148","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s42255-020-0171-3","article-title":"Targeted pharmacological therapy restores \u03b2-cell function for diabetes remission","volume":"2","author":"Sachs","year":"2020","journal-title":"Nat Metab"},{"key":"10.1124\/pharmrev.124.001074_bib149","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/diabetes.51.6.1663","article-title":"Direct and indirect effects of insulin on glucose uptake and storage by the liver","volume":"51","author":"Satake","year":"2002","journal-title":"Diabetes"},{"key":"10.1124\/pharmrev.124.001074_bib150","series-title":"Handbook of Diabetes Technology","first-page":"47","article-title":"The implantable insulin pump","author":"Schaepelynck","year":"2019"},{"key":"10.1124\/pharmrev.124.001074_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/2230-973X.176456","article-title":"Insulin delivery methods: past, present and future","volume":"6","author":"Shah","year":"2016","journal-title":"Int J Pharm Investig"},{"issue":"Suppl 2","key":"10.1124\/pharmrev.124.001074_bib152","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.2337\/dc08-s264","article-title":"Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?","volume":"31","author":"Shanik","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1124\/pharmrev.124.001074_bib153","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1080\/09205063.2022.2068947","article-title":"Preparation and in-vitro, in-vivo characterisation of pioglitazone loaded chitosan\/PEG blended PLGA biocompatible nanoparticles","volume":"33","author":"Sharma","year":"2022","journal-title":"J\u00a0Biomater Sci Polym Ed"},{"key":"10.1124\/pharmrev.124.001074_bib154","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1080\/03639045.2019.1680992","article-title":"B\u00dcCHI nano spray dryer B-90: a promising technology for the production of metformin hydrochloride-loaded alginate-gelatin nanoparticles","volume":"45","author":"Shehata","year":"2019","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1124\/pharmrev.124.001074_bib155","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1080\/10717544.2022.2036873","article-title":"Construction and performance of exendin-4-loaded chitosan-PLGA microspheres for enhancing implant osseointegration in type 2 diabetic rats","volume":"29","author":"Shi","year":"2022","journal-title":"Drug Deliv"},{"key":"10.1124\/pharmrev.124.001074_bib156","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s41598-021-81024-x","article-title":"Self-monitoring of blood glucose in association with glycemic control in newly diagnosed non-insulin-treated diabetes patients: a retrospective cohort study","volume":"11","author":"Sia","year":"2021","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.124.001074_bib157","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-021-01418-2","article-title":"100 years of insulin: celebrating the past, present and future of diabetes therapy","volume":"27","author":"Sims","year":"2021","journal-title":"Nat Med"},{"key":"10.1124\/pharmrev.124.001074_bib158","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2217\/nnm-2017-0278","article-title":"Insulin- and quercetin-loaded liquid crystalline nanoparticles: implications on oral bioavailability, antidiabetic and antioxidant efficacy","volume":"13","author":"Singh","year":"2018","journal-title":"Nanomedicine (Lond)"},{"key":"10.1124\/pharmrev.124.001074_bib159","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245395","article-title":"Effect of honey and insulin treatment on oxidative stress and nerve conduction in an experimental model of diabetic neuropathy Wistar rats","volume":"16","author":"Sirisha","year":"2021","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.124.001074_bib160","doi-asserted-by":"crossref","first-page":"840","DOI":"10.5114\/aoms.2015.53304","article-title":"Sulfonylureas and their use in clinical practice","volume":"11","author":"Sola","year":"2015","journal-title":"Arch Med Sci"},{"key":"10.1124\/pharmrev.124.001074_bib161","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1039\/b800422f","article-title":"The impact of flavonoids on memory: physiological and molecular considerations","volume":"38","author":"Spencer","year":"2009","journal-title":"Chem Soc Rev"},{"key":"10.1124\/pharmrev.124.001074_bib162","author":"Starling","year":"2021","journal-title":"Genetics of T2D. Nature Milestones: Diabetes"},{"key":"10.1124\/pharmrev.124.001074_bib163","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3390\/pharmaceutics14071406","article-title":"A\u00a0comprehensive review of the evolution of insulin development and its delivery method","volume":"14","author":"Sugumar","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1124\/pharmrev.124.001074_bib164","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/08982104.2017.1343835","article-title":"Niosomes for oral delivery of nateglinide: in situ-in\u00a0vivo correlation","volume":"28","author":"Sultan","year":"2018","journal-title":"J\u00a0Liposome Res"},{"key":"10.1124\/pharmrev.124.001074_bib165","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/fft2.15","article-title":"Dietary polyphenols as antidiabetic agents: advances and opportunities","volume":"1","author":"Sun","year":"2020","journal-title":"Food Front"},{"key":"10.1124\/pharmrev.124.001074_bib166","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1039\/D0FO02387F","article-title":"Resveratrol attenuates dapagliflozin-induced renal gluconeogenesis via activating the PI3K\/Akt pathway and suppressing the FoxO1 pathway in type 2 diabetes","volume":"12","author":"Sun","year":"2021","journal-title":"Food Funct"},{"key":"10.1124\/pharmrev.124.001074_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajmo.2023.100031","article-title":"The importance of exercise for glycemic control in type 2 diabetes","volume":"9","author":"Syeda","year":"2023","journal-title":"Am J Med Open"},{"key":"10.1124\/pharmrev.124.001074_bib168","first-page":"325","article-title":"Anti-diabetic effect of cotreatment with resveratrol and pioglitazone in diabetic rats","volume":"27","author":"Tamimi","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1124\/pharmrev.124.001074_bib169","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.3390\/ijms23052522","article-title":"Pioglitazone-loaded PLGA nanoparticles: towards the most reliable synthesis method","volume":"23","author":"Todaro","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.124.001074_bib170","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.124.001074_bib171","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.actbio.2018.09.049","article-title":"Nanoparticulate-based drug delivery systems for small molecule anti-diabetic drugs: an emerging paradigm for effective therapy","volume":"81","author":"Uppal","year":"2018","journal-title":"Acta Biomater"},{"key":"10.1124\/pharmrev.124.001074_bib172","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41551-021-00698-w","article-title":"The evolution of commercial drug delivery technologies","volume":"5","author":"Vargason","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1124\/pharmrev.124.001074_bib173","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/advances\/nmz038","article-title":"The gastrointestinal tract as prime site for cardiometabolic protection by dietary polyphenols","volume":"10","author":"Villa-Rodriguez","year":"2019","journal-title":"Adv Nutr"},{"key":"10.1124\/pharmrev.124.001074_bib174","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202201822","article-title":"Partially oxidized alginate as a biodegradable carrier for glucose-responsive insulin delivery and islet cell replacement therapy","volume":"12","author":"Volpatti","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"10.1124\/pharmrev.124.001074_bib175","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/acsnano.9b06395","article-title":"Glucose-responsive nanoparticles for rapid and extended self-regulated insulin delivery","volume":"14","author":"Volpatti","year":"2020","journal-title":"ACS Nano"},{"key":"10.1124\/pharmrev.124.001074_bib176","article-title":"Glucose-responsive insulin and delivery systems: innovation and translation","volume":"32","author":"Wang","year":"2020","journal-title":"Adv Mater"},{"key":"10.1124\/pharmrev.124.001074_bib177","article-title":"Charge-switchable polymeric complex for glucose-responsive insulin delivery in mice and pigs","volume":"5","author":"Wang","year":"2019","journal-title":"Sci Adv"},{"key":"10.1124\/pharmrev.124.001074_bib178","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0140-6736(08)60762-X","article-title":"Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial","volume":"371","author":"Weng","year":"2008","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.124.001074_bib179","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bcp.2017.03.012","article-title":"Role of the small intestine, colon and microbiota in determining the metabolic fate of polyphenols","volume":"139","author":"Williamson","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.124.001074_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e14796","article-title":"The development of an in-situ biopolymer-based floating gel for the oral delivery of metformin hydrochloride","volume":"9","author":"Wiwattanapatapee","year":"2023","journal-title":"Heliyon"},{"key":"10.1124\/pharmrev.124.001074_bib181","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1464-5491.2011.03552.x","article-title":"Acceptance of insulin therapy: a long shot? Psychological insulin resistance in primary care","volume":"29","author":"Woudenberg","year":"2012","journal-title":"Diabet Med"},{"key":"10.1124\/pharmrev.124.001074_bib182","doi-asserted-by":"crossref","first-page":"19787","DOI":"10.1002\/anie.202008879","article-title":"Oral insulin delivery platforms: strategies to address the biological barriers","volume":"59","author":"Xiao","year":"2020","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1124\/pharmrev.124.001074_bib183","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41551-019-0508-y","article-title":"Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs","volume":"4","author":"Yu","year":"2020","journal-title":"Nat Biomed Eng"},{"key":"10.1124\/pharmrev.124.001074_bib184","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1080\/10717544.2020.1850919","article-title":"Exenatide-loaded inside-porous poly(lactic-co-glycolic acid) microspheres as a long-acting drug delivery system with improved release characteristics","volume":"27","author":"Zhai","year":"2020","journal-title":"Drug Deliv"},{"key":"10.1124\/pharmrev.124.001074_bib185","series-title":"Advances in Food and Nutrition Research","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.afnr.2021.11.002","article-title":"Stability of polyphenols in food processing","author":"Zhang","year":"2022"},{"key":"10.1124\/pharmrev.124.001074_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122279","article-title":"Co-delivery of saxagliptin and dapagliflozin by electrosprayed trilayer poly (D, L-lactide-co-glycolide) nanoparticles for controlled drug delivery","volume":"628","author":"Zhang","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1124\/pharmrev.124.001074_bib187","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.addr.2018.12.006","article-title":"Advances in transdermal insulin delivery","volume":"139","author":"Zhang","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/pharmrev.124.001074_bib188","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cell.2020.02.001","article-title":"Targeting strategies for tissue-specific drug delivery","volume":"181","author":"Zhao","year":"2020","journal-title":"Cell"},{"key":"10.1124\/pharmrev.124.001074_bib189","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1208\/s12249-018-1208-8","article-title":"Formation mechanism, in\u00a0vitro and in\u00a0vivo evaluation of dimpled exenatide loaded PLGA microparticles prepared by ultra-fine particle processing system","volume":"20","author":"Zhu","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1124\/pharmrev.124.001074_bib190","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMoa1003795","article-title":"Severe hypoglycemia and risks of vascular events and death","volume":"363","author":"Zoungas","year":"2010","journal-title":"N\u00a0Engl J Med"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724000036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724000036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/pharmrev.124.001074","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:00:15Z","timestamp":1777435215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699724000036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":190,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0031699724000036"],"URL":"https:\/\/doi.org\/10.1124\/pharmrev.124.001074","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospects for the convergence of polyphenols with pharmaceutical drugs in type 2 diabetes: Challenges, risks, and strategies","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/pharmrev.124.001074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100003"}}